DCVC Bio GP, LLC portfolio
Latest available portfolio: Q2 2022 · Holdings as of · Filed · in Form 13F holdings
See latest portfolio changes
$313K
Full value: $313,000 · USD · 30 Jun 2022Quarterly portfolio filings
Choose a quarter to see holdings and changes. Newer portfolio dates appear first.
Estimated additions and reductions value share changes at filing-derived prices; they are not actual trade proceeds or costs.
| Quarter | Holdings | SEC-reported value | Est. additions | Est. reductions | Est. net | Top Holdings | Form Type | Accepted by SEC |
|---|---|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | $0 | -$313,000 | -$313,000 | 13F-HR | 14 Nov 2022, 09:28 | |
| Q2 2022 | 1 | $313,000 | $0 | -$77,436,930 | -$77,436,930 | ABCL | 13F-HR | 14 Nov 2022, 09:28 |
| Q1 2022 | 1 | $71,231,000 | $0 | $0 | $0 | ABCL | 13F-HR | 14 Nov 2022, 09:28 |
| Q4 2021 | 1 | $104,472,000 | $0 | $0 | $0 | ABCL | 13F-HR | 14 Feb 2022, 15:18 |
Showing 1-4 of 4 filings.
Manager details and filing context
- Form 13F summary
-
- DCVC Bio GP, LLC Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
- Form 13F is generally due within 45 days after each calendar quarter ends.
- DCVC Bio GP, LLC reported 1 equity holding with a total reported market value of $313,000 for Q2 2022.
- Manager signature
- Zachary Bogue - Managing Member of a Managing Member
- Manager location
- Palo Alto, CA
13F snapshot
Latest parsed holdings, value, and filing-period context.
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Holdings Value